| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,160 | 0,210 | 07:46 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| QLIFE Aktie jetzt für 0€ handeln | |||||
| Do | QLife Holding AB: The subscription period in Qlife's rights issue begins today | 55 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| Mi | QLife Holding AB: Qlife publishes information document due to upcoming rights issue | 63 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 27.02. | QLife Holding AB: Qlife announces that two investors have entered agreements to subscribe for shares if the rights issue is subscribed below approx. 51.0 percent, taking over commitments from a group of guarantors | 90 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 27.02. | XFRA CAPITAL ADJUSTMENT INFORMATION - 27.02.2026 | 207 | Xetra Newsboard | Das Instrument UZ9 CA4577022078 INSPIRATION ENERGY CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 27.02.2026 und ex Kapitalmassnahme am 02.03.2026 The instrument UZ9 CA4577022078 INSPIRATION ENERGY... ► Artikel lesen | |
| 26.02. | QLife Holding AB: Bulletin from Extraordinary General Meeting 2026 of Qlife Holding AB | 87 | GlobeNewswire (Europe) | Qlife Holding AB (the "Company" or "Qlife") held an Extraordinary General Meeting on 26 February 2026, at which the following resolutions were adopted.
Resolution on amendment of the Articles of Association
The... ► Artikel lesen | |
| 25.02. | QLIFE HOLDING AB: Qlife launches pharmacy pilot project in Nordic markets | 2 | Cision News | ||
| 19.02. | QLIFE HOLDING AB: Guarantor converts guarantee commitment of SEK 0.5 million into binding subscription commitment and top guarantor waives guarantee compensation in Qlife's ongoing rights issue | 1 | Cision News | ||
| 12.02. | The observation status for Qlife Holding AB is updated | 120 | GlobeNewswire | On June 5, 2025, the shares in Qlife Holding AB (the "Company") were given observation status with reference to the Company's decision to enter into a letter of intent for a reverse takeover of Hipro... ► Artikel lesen | |
| 11.02. | Qlife Holding AB Q4 Sales Decline | - | RTTNews | ||
| 11.02. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October - December 2025 | 124 | GlobeNewswire (Europe) | Positioned for scale in 2026
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - fourth quarter 2025
On 5. October... ► Artikel lesen | |
| 26.01. | Notice of Extraordinary General Meeting 2026 in Qlife Holding AB | 2 | Cision News | ||
| 26.01. | QLife Holding AB: Qlife submits Egoo PHE home testing system for regulatory approval | 343 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, today announces that the Company has formally submitted its Egoo PHE home-testing system for regulatory approval... ► Artikel lesen | |
| 22.01. | QLife Holding AB: Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan agreements and postpones the exercise period of warrants TO7 | 108 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 19.01. | QLIFE HOLDING AB: Qlife prepares for pharmacy testing in Nordic markets | 1 | Cision News | ||
| 15.01. | QLife Holding AB: Egoo Health achieves breakthrough precision in key diabetes biomarker test, paving the way for partnerships | 137 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, together with its partner Hipro Biotechnology Co., Ltd. ("Hipro"), announces a major milestone: the Egoo HbA1c... ► Artikel lesen | |
| 23.12.25 | QLife Holding AB: Qlife provides end-year operational update on key issues | 531 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, provides a year-end operational update on key issues.
Diabetes data
Egoo Health has achieved breakthrough... ► Artikel lesen | |
| 16.12.25 | QLife Holding AB: Qlife and Hipro sign exclusive commercial agreement covering Qlife's sale of Hipro products in EU and US markets | 191 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a first mover in clinical-grade home diagnostics, today announced that it has entered into an exclusive commercial agreement with Hipro Biotechnology Co.... ► Artikel lesen | |
| 16.12.25 | QLife Holding AB: The Letter of Intent with Hipro Biotechnology regarding the reverse takeover has been extended until 31 December 2026 and the valuation term will re-evaluated once a structure has been established | 252 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") announces an extension of the non-binding Letter of Intent regarding the potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd.... ► Artikel lesen | |
| 12.12.25 | QLife Holding AB: Egoo Health powers AI-driven personalized diabetes management in China | 220 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") is proud to announce that its Egoo Health blood testing platform will play a central role in a groundbreaking project launched by Hipro Biotechnology Co.... ► Artikel lesen | |
| 05.12.25 | QLife Holding AB: Qlife's Birmingham PKU clinical trial published with strong results - key milestone toward CE-mark submission and market launch | 154 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") a first mover in clinical-grade home diagnostics, announces publication of the clinical study for PKU children and adolescents under 18 years of age. The... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,400 | 0,00 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius von 55 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst James Vane-Tempest hob am Sonntag im... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,500 | 0,00 % | Siemens Healthineers: Stabilität als strategischer Vorteil | ||
| FRESENIUS MEDICAL CARE | 39,700 | 0,00 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 47,50 auf 46,50 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Das Wachstum der Behandlungszahlen... ► Artikel lesen | |
| GERRESHEIMER | 18,120 | 0,00 % | Kursexplosion und Kursalarm! Gerresheimer, Nordex und KI-Profiteuer American Atomics! | Kursexplosion bei Nordex. Nach starken Quartalszahlen schießt die Aktie an einem Tag um rund 17 % nach oben. Das Unternehmen schwimmt auf einer Erfolgswelle und der Auftragsbestand deutet darauf hin... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,380 | 0,00 % | INDEX-MONITOR: Lufthansa verpasst Dax-Rückkehr - Nur Wechsel in MDax und SDax | ZUG (dpa-AFX) - Die Aktien von Lufthansa haben die Rückkehr in den deutschen Leitindex Dax verpasst. Wie der zur Deutschen Börse gehörende Index-Anbieter Stoxx am späten Mittwochabend mitteilte, bleibt... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,790 | -0,41 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 72,16 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| GENEDX | 82,09 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 17,610 | -1,07 % | INVO Fertility, Inc.: INVO Fertility's Wisconsin Clinic Joins Progyny Network | ||
| ECKERT & ZIEGLER | 14,990 | 0,00 % | Eckert&Ziegler-Aktie: Überraschende Wendung in der Kursentwicklung - Was steckt dahinter? | ||
| PROCEPT BIOROBOTICS | 25,360 | 0,00 % | Truist cuts Procept BioRobotics stock price target on lower forecasts | ||
| OTTOBOCK | 57,20 | 0,00 % | Ottobock greift nach der "Gedanken-Hand": 5 Mio. US-Dollar in Neuro-Implantate - nächster Gamechanger in der Prothetik? | Ottobock setzt beim nächsten Innovationssprung in der Prothetik auf eine klare Botschaft: Kapital plus Kontrolle. Im Rahmen einer Series-A-Finanzierung investiert der Human-Bionics-Marktführer 5 Mio.... ► Artikel lesen | |
| DRAEGERWERK | 87,80 | 0,00 % | Draegerwerk AG & Co. KGaA: Zollentlastung bereits eingepreist, Aufwärtspotenzial wird kleiner, Kursziel erhöht; auf HALTEN gestuft. | Die Zollerlassungen in den USA bieten einen inkrementellen Unterstützungseffekt für die Draegerwerk, jedoch wird der Nutzen voraussichtlich schrittweise erfolgen. Während bestimmte Zölle aufgehoben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,590 | -1,43 % | Sekundärplatzierung belastet Alignment Healthcare-Aktie | ||
| LIFESTANCE HEALTH GROUP | 6,945 | -5,19 % | LifeStance Health Group, Inc. - 8-K, Current Report |